Asthma |
Bronchial Asthma |
Clinical Trial: Efficacy and Safety of Xolair in Children (6 - <12 years) with Moderate-Severe, Inadequately Controlled Allergic Asthma
This study is currently recruiting patients.
|
Purpose
A substance called immunoglobulin E (IgE), which is naturally produced by our body, has a key role in generating asthma attacks. In patients with allergies, there is an exaggerated production of IgE in response to specific substances such as pollens. Omalizumab (Xolair®) is a new drug that inactivates IgE. This study will test the safety and efficacy of omalizumab against asthma attacks in children with allergic asthma.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Asthma | Drug: Omalizumab | Phase III |
MedlinePlus related topics: Asthma
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Study start: March 2004
This study is designed to provide one year efficacy and safety data for subcutaneous (SQ) omalizumab, compared to placebo in children (6 to < 12 years) with moderate to severe persistent asthma who have inadequate asthma control despite treatment according to NHLBI step 3 or 4 (at least medium dose inhaled corticosteroids with or without other controller asthma medications).
Eligibility
Ages Eligible for Study: 6 Years - 12 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria
- History of asthma attacks
- Elevated IgE levels
Exclusion Criteria
- History of severe allergy to food or drugs
- Previous treatment with omalizumab(Xolair®)
- Very low or high body weight
Other protocol-defined exclusion criteria may apply.
Location and Contact Information
Alabama
Alabama Allergy and Asthma Center, Birmingham, Alabama, 35209, United States; Recruiting
Carol Smith, MD, Principal Investigator
Arkansas
University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72202, United States; Recruiting
California
Allergy and Asthma Associates of Santa Clara Valley RC, San Jose, California, 95117, United States; Recruiting
Dr. Alan Goldsobel, Principal Investigator
Allergy and Asthma Medical Group & Research Center, San Diego, California, 92123, United States; Recruiting
Allergy Associates Medical Group, San Diego, California, 92120, United States; Recruiting
Pediatric Care and Medical Group, Huntington Beach, California, 92647, United States; Recruiting
Dr. Paul Quaqundah, Principal Investigator
Allergy & Asthma Med Group of Diablo Valley CR, Walnut Creek, California, 94598, United States; Recruiting
Allergy and Asthma Specialists Medical Group, Huntington Beach, California, 92647, United States; Recruiting
Kaiser Permanente, San Diego, California, 92111, United States; Recruiting
Integrated Research Group, Riverside, California, 92506, United States; Recruiting
Dr. Joann Blessing-Moore, Palo Alto, California, 94304, United States; Recruiting
Joann Blessing-Moore, MD, Principal Investigator
Palo Alto, California, 94304, United States; Recruiting
JoAnn Blessing-Moore, MD, Principal Investigator
Children's Hosptial of Orange County, Div Asthma, Allergy & Immunology, Orange, California, 92868, United States; Recruiting
Mark Ellis, MD, Principal Investigator
West Coast Clinical Trials, Long Beach, California, 90806, United States; Recruiting
Kenneth Kim, MD, Principal Investigator
CA Allergy & Asthma Med Group, Palmdale, California, 93551, United States; Recruiting
Ricardo Tan, MD, Principal Investigator
Children's Hospital Los Angeles Allergy & Immunology, Los Angeles, California, 90027, United States; Recruiting
Southern California Research Center, Mission Viejo, California, 92691, United States; Recruiting
William Berger, Principal Investigator
Bensch Research Associates, Stockton, California, 95207, United States; Recruiting
Capital Allergy & Respiratory Disease Clinic, Sacramento, California, 95819, United States; Recruiting
Colorado
National Jewish Medical and Research Center, Denver, Colorado, 80206, United States; Recruiting
Florida
Miami Children's Hospital, Miami, Florida, 33155, United States; Recruiting
Dr. Maria Franco, Principal Investigator
The Nemours Children's Clinic, Orlando, Florida, 32806, United States; Recruiting
Dr. David Geller, Principal Investigator
Allergy and Asthma Care, Ocala, Florida, 34471, United States; Recruiting
University of Miami--Bachelor Children's Research Institute, Miami, Florida, 33136, United States; Recruiting
Giovanni Piedmont, MD, Principal Investigator
Georgia
Allergy and Asthma Clinics of Georgia, Columbus, Georgia, 31904, United States; Recruiting
Dr. Robert Chrzanowski, Principal Investigator
Dr. Tracy Bridges, Principal Investigator
Family Allergy and Asthma Center, PC, Atlanta, Georgia, 30342, United States; Recruiting
Center for Allergy & Asthma, Carrollton, Georgia, 30117, United States; Recruiting
Eugene Hurwitz, MD, Principal Investigator
Atlanta Center for Clinical Research, Woodstock, Georgia, 30188, United States; Recruiting
Jessenko Vukotic, MD, Principal Investigator
Allergy & Asthma Clinic of Northeast Georgia, Gainesville, Georgia, 30501, United States; Recruiting
John Yarbrough, MD, Principal Investigator
Allergy & Asthma Clinics of Georgia, Albany, Georgia, 31707, United States; Recruiting
Georgia Pollens, Albany, Georgia, 31707, United States; Recruiting
Tracy Bridges, MD, Principal Investigator
Aeroallergy Research Labs of Savannah, Inc, Savannah, Georgia, 31406, United States; Recruiting
Brad Goodman, MD, Principal Investigator
Center for Allergy & Asthma, Carrollton, Georgia, 30117, United States; Recruiting
Eugene Hurwitz, MD, Principal Investigator
Northeast Georgia Research Center, Gainesville, Georgia, 30501, United States; Recruiting
John Yarbrough, MD, Principal Investigator
Illinois
Rush University Medical Center, Chicago, Illinois, 60612, United States; Recruiting
Indiana
Riley Children's Hospital, Indianapolis, Indiana, 46203, United States; Recruiting
Louisiana
AAI Asthma, Allergy, Immunology, Covington, Louisiana, 70433, United States; Recruiting
Richard Guillot, MD, Principal Investigator
Maryland
Dr. Glenn Silber, Elliott City, Maryland, 21042, United States; Recruiting
Chesapeake Clinical Research, Baltimore, Maryland, 21236, United States; Recruiting
Jonathan Matz, MD, Principal Investigator
Massachusetts
Northeast Med Research Associates, North Dartmouth, Massachusetts, 02747, United States; Recruiting
Dr. David Miller, Principal Investigator
Minnesota
Children's Respiratory and Critical Care Specialists, Minneapolis, Minnesota, 55404, United States; Recruiting
Mayo Clinic, Rochester, Minnesota, 55905, United States; Recruiting
Missouri
St. Louis University School of Medicine, St. Louis, Missouri, 63104, United States; Recruiting
St. John's Medical Clinic, Springfield, Missouri, 65807, United States; Recruiting
Dr. Gregory Lux, Principal Investigator
Nebraska
Midwest Allergy & Asthma Clinic, Omaha, Nebraska, 68114, United States; Recruiting
New York
Island Medical Research (Allergy and Asthma Center), Rockville Center, New York, 11570, United States; Recruiting
Dr. Stanley Goldstein, Principal Investigator
Galisano Children's Hospital at Strong Div of Pediatric Pulm & Allergy, Rochester, New York, 14642, United States; Recruiting
The Long Island College Hospital, Brooklyn, New York, 11201, United States; Recruiting
Bernard Silverman, MD, Principal Investigator
Children’s Medical Group, Poughkeepsie, New York, 12603, United States; Recruiting
Herschel Lessin, MD, Principal Investigator
The Children’s Medical Group, PLLC, Poughkeepsie, New York, 12603, United States; Recruiting
Herschel Lessin, MD, Principal Investigator
Long Island College Hospital--Allergy & Immunology Dept., Brooklyn, New York, 11201, United States; Recruiting
Bernard Silverman, MD, Principal Investigator
North Carolina
Duke University Medical Center, Durham, North Carolina, 27710, United States; Recruiting
Ohio
Columbus Childrens, The Ohio State University, Columbus, Ohio, 43205, United States; Recruiting
Dr. Richard Shell, Principal Investigator
Bernstein Clinical Research Center, Cincinnati, Ohio, 45231, United States; Recruiting
Jonathan Bernstein, MD, Principal Investigator
Bernstein Clinical Research, Cincinatti, Ohio, 45231, United States; Recruiting
Jonathan Bernstein, MD, Principal Investigator
Pennsylvania
Hershey Medical Ctr Allergy Clinic & Asthma Research, Hershey, Pennsylvania, 17033-2360, United States; Recruiting
Dr. Timothy Craig, Principal Investigator
West Penn Allegheny General Health System, Pittsburgh, Pennsylvania, 15212, United States; Recruiting
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States; Recruiting
Dr. Jonathan Spergel, Principal Investigator
Rhode Island
Allergy & Asthma Center, Providence, Rhode Island, 02906, United States; Recruiting
Dr. Robert Settipane, Principal Investigator
AAPRI Clinical Research Institute, Lincoln, Rhode Island, 02865, United States; Recruiting
John Zwetchkenbaum, MD, Principal Investigator
AAPRI Clinical Research Institute, Lincoln, Rhode Island, 02865, United States; Recruiting
John Zwetchkenbaum, MD, Principal Investigator
Tennessee
Vanderbilt University, Nashville, Tennessee, 37203, United States; Recruiting
Texas
North Texas Institute for Clinical Trials, Ft. Worth, Texas, 76132, United States; Recruiting
UTHSC-Houston, Houston, Texas, 77030, United States; Recruiting
Dr. Gailen Marshall, Principal Investigator
Pediatric Allergy/Immunology Associates, PA, Dallas, Texas, 75230, United States; Recruiting
Sylvanna Research, San Antonio, Texas, 78229, United States; Recruiting
Baylor College of Medicine, Houston, Texas, 77030, United States; Recruiting
Stuart Abramson, MD, Principal Investigator
Allergy & Asthma Center of El Paso, El Paso, Texas, 79925, United States; Recruiting
Rodger Menedez, MD, Principal Investigator
Pediatric Pulmonary Association of North Texas, Dallas, Texas, 75230, United States; Recruiting
Richard Silver, MD, Principal Investigator
Utah
Copperview Medical Center, South Jordan, Utah, 84095, United States; Recruiting
Paul Shing-Jian Lei, MD, Principal Investigator
Copperview Medical Ct, South Jordan, Utah, 84095, United States; Recruiting
Paul Shing-Jian Lei, MD, Principal Investigator
Washington
A.S.T.H.M.A., Inc., Seattle, Washington, 98105, United States; Recruiting
Dr. Stephen Tilles, Principal Investigator
Wisconsin
Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States; Recruiting
More Information
Novartis Study IA05 web site
http://www.pediatricasthmastudy.com
Record last reviewed: March 2005
Last Updated: March 25, 2005
Record first received: March 18, 2004
ClinicalTrials.gov Identifier: NCT00079937
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


